Relaying what matters next.
The Relay is a new media project dedicated to covering slightly futuristic domains such as artificial intelligence, space exploration, longevity science, crypto and blockchain, advanced biology, and defense technologies. Our mission is to capture the signals of tomorrow and relay them forward with clarity, depth, and context.
What's happening today?
EDAM vs. Markets+: The West’s Two-Market Era Begins
FERC’s 5 approvals turned CAISO’s EDAM and SPP’s Markets+ from concepts into timetables. See the 2026–2027 launch windows, which utilities are lining up where, and how the two-market era could reshape prices, reliability and curtailment across the West.
Project Pele Enters Build Phase as BWXT Starts Core
The Pentagon’s transportable microreactor is moving from drawings to hardware. With BWXT starting TRISO core fabrication and INL readying the test site, the 1-5 MWe unit is edging toward trials that could change deployed power.
Fidelity puts Treasuries on Ethereum. The cash race begins
Fidelity is rolling out an Ethereum-based share class for its Treasury fund, turning regulated cash into wallet-native collateral. Here is how it reshapes stablecoins, DeFi, and the competition with BlackRock and Franklin Templeton.
Identity Is the Control Plane: Okta’s XAA Playbook
Okta’s Cross App Access turns identity into the control plane for AI agents. See how XAA curbs agent sprawl, enforces least privilege, complements MCP, and how to roll it out with a practical, step by step playbook.
GPX4 Senolytics Hit Clinic: Rubedo’s RLS‑1496 Moves Into Humans
Rubedo dosed its first patient with RLS-1496 in May 2025, launching the first human test of a GPX4-modulating senolytic. Here is how ferroptosis could define senolytics 2.0, which skin biomarkers will matter, and what a credible 2026 systemic program could look like.
NECEC goes live: 1.2 GW hydro reshapes New England winter
New England enters a different kind of winter. As NECEC begins delivering firm Hydro-Québec power, ISO-NE should see fewer price spikes, lower gas burn and emissions, and shifting capacity and REC dynamics that reward resources that perform in the cold.
Poland’s IBCS live-fire makes plug-and-fight real for NATO
Poland’s September 16, 2025 live-fire in Ustka moved IBCS from promise to practice, linking Patriot now and paving the way for CAMM. See what plug-and-fight means for NATO integrated air and missile defense, the fielding timeline to watch, and the hardest problems left to solve.
3I/ATLAS: Why This Interstellar Comet Matters Right Now
The third interstellar comet ever discovered is racing through the inner solar system in 2025. See what telescopes are finding, when to look, and how 3I/ATLAS could reshape theories of how planets form.
Apple quietly lays MCP rails in iOS 26.1 and macOS 26.1
Code in the September 22-23 developer betas points to system-level support for Anthropic’s Model Context Protocol inside App Intents. Here is how that could unlock secure cross-app agents on iPhone and Mac and what developers should do now.
Stacks lifts sBTC cap: open minting and real BTC withdrawals
Stacks removed the sBTC cap in mid September 2025, opening permissionless minting and live L1 withdrawals. Here is why that shift matters for BTCFi, how it compares to wBTC, what the early data shows, and the risks to watch.
Golden Dome Goes Public: Space Defense Enters Acquisition
Golden Dome has moved from presidential reveal to acquisition. Here is what the selected architecture, Guetlein’s mandate, budgets, timelines, NORAD integration, industry capacity, and the test-and-risk outlook mean for fielding by 2029.
Blue Alchemist Clears CDR, Bringing Lunar Factories Near
Blue Origin’s Blue Alchemist has passed Critical Design Review, moving molten regolith electrolysis from pitch deck to practice. Here’s how a 2026 autonomous demo could unlock lunar oxygen, metals, and locally made solar power for Artemis.
Plasma Exchange’s 2025 Pivot: Human Data and Expansion
A randomized human study in 2025 reported multi-omics rejuvenation signals after therapeutic plasma exchange, strongest when IVIG was added. Here is what the data means, how clinics plan to scale, and what the next randomized trials must prove.
SEC clears generic ETP rules as altcoin ETFs line up
On September 17, 2025, the SEC approved generic listing standards for commodity ETPs, giving U.S. spot crypto funds a faster path to market. With a multi-coin ETF already live, SOL and XRP products could arrive as soon as October, reshaping liquidity and on-chain behavior.
Microsoft 365 Copilot goes multi-model with Anthropic Claude
Microsoft is bringing Anthropic’s Claude to Microsoft 365 Copilot and Copilot Studio, enabling true model choice. Here is what changes, the governance you need, and a 30-day integration plan.
Two B-21s, One Sprint: Dual-Ship Tests Rewrite Bomber Plans
A second B-21 Raider has joined flight test at Edwards AFB, unlocking parallel mission systems and weapons work while reducing production risk. Here’s how dual-ship trials quicken combat capability and sharpen Indo-Pacific strike concepts.
PEARL’s year-long rapamycin trial: what it really shows
PEARL's 48-week randomized trial in healthy adults reports acceptable safety, sex-specific gains in lean mass, and less pain in women, with no change in visceral fat. Here is what that means for healthspan and what a real Phase 3 must prove.
June 2025 Tariffs Reset U.S. Solar: Prices, Risk, Timelines
New AD and CVD orders on Southeast Asian solar imports reset U.S. module prices and project timelines. Here is what changed on April 21 and June 24, how landed costs now stack up, who can fill the gap, and the moves to make in the next 90 days.

















